Results 21 to 30 of about 147,146 (257)

Interpretation of the Essential Updates in 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure [PDF]

Zhongguo quanke yixue, 2022
The American Heart Association (AHA) , American College of Cardiology (ACC) and Heart Failure Society of America (HFSA) jointly released the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (hereinafter referred to as the 2022 Guideline) .
Yifang GUO
doaj   +1 more source

Fractional flow reserve in patients with reduced ejection fraction

European Heart Journal, 2019
Abstract Aims Fractional flow reserve (FFR) has never been investigated in patients with reduced ejection fraction and associated coronary artery disease (CAD). We evaluated the impact of FFR on the management strategies of these patients and related outcomes.
Giuseppe Di Gioia, Bernard De Bruyne, Mariano Pellicano, Jozef Bartunek, Iginio Colaiori, Antonella Fiordelisi, Grazia Canciello, Panagiotis Xaplanteris, Stephane Fournier, Asim Katbeh, Danilo Franco, Monika Kodeboina, Carmine Morisco, Frank Van Praet, Filip Casselman, Ivan Degrieck, Bernard Stockman, Marc Vanderheyden, Emanuele Barbato   +18 more
openaire   +3 more sources

Autonomic cardiovascular reflex control of hemodynamics during exercise in heart failure with reduced ejection fraction and the effects of exercise training [PDF]

Reviews in Cardiovascular Medicine, 2022
Heart failure with reduced ejection fraction is associated with increased exercise intolerance, morbidity, and mortality. Importantly, exercise intolerance in heart failure with reduced ejection fraction is a key factor limiting patient quality of ...
Natasha G. Boyes, Darcy D. Marciniuk, Haissam Haddad, Corey R. Tomczak   +3 more
doaj   +1 more source

Plasma levels of free fatty acid differ in patients with left ventricular preserved, mid-range, and reduced ejection fraction

BMC Cardiovascular Disorders, 2018
Background Free fatty acids (FFAs) predicted the risk of heart failure (HF) and were elevated in HF with very low left ventricular ejection fraction (LVEF) compared to healthy subjects. The aim of this study was to investigate whether total levels of FFA
Ning Zhu, Wenbing Jiang, Yi Wang, Youyang Wu, Hao Chen, Xuyong Zhao   +5 more
doaj   +1 more source

Five‐year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort

ESC Heart Failure, 2022
Aims Available evidence is incomplete and inconsistent in the outcomes of heart failure (HF) patients with preserved ejection fraction (HFpEF), mildly reduced ejection fraction (HFmrEF), and reduced ejection fraction (HFrEF).
Shiqun Chen, Zhidong Huang, Yan Liang, Xiaoli Zhao, Xiemuxikaimaier Aobuliksimu, Bo Wang, Yibo He, Yu Kang, Haozhang Huang, Qiang Li, Younan Yao, Xiaozhao Lu, Xiaoxian Qian, Xujing Xie, Jin Liu, Yong Liu   +15 more
doaj   +1 more source

Association of Depression and Anxiety with Cardiac Structural and Functional Characteristics in Heart Failure with Reduced and Mildly Reduced Ejection Fraction

Clinics and Practice, 2023
Heart failure and mental health conditions frequently coexist and have a negative impact on health-related quality of life and prognosis. We aimed to evaluate depression and anxiety symptoms and to determine the association between psychological distress
Timea Magdolna Szabo, Előd Ernő Nagy, Ádám Kirchmaier, Erhard Heidenhoffer, Hunor-László Gábor-Kelemen, Marius Frăsineanu, Attila Frigy   +6 more
doaj   +1 more source

Obesity paradox in chronic heart failure with moderately reduced or preserved left ventricular ejection fraction: impact on a prognosis for patients according to a five-year follow-up

Zaporožskij Medicinskij Žurnal, 2023
Aim. To investigate the obesity paradox by studying the impact of overweight and abdominal obesity on the prognosis in chronic heart failure (CHF) patients with moderately reduced or preserved left ventricular ejection fraction (LVEF) by five-year follow-
P. P. Bidzilya, V. H. Kadzharian, M. V. Bychko   +2 more
doaj   +1 more source

SGLT2 inhibitors in heart failure with reduced ejection fraction

The Egyptian Heart Journal, 2021
Sodium – glucose co-transporter 2 (SGLT2) inhibitors reduce blood glucose by inhibiting reabsorption of glucose from the proximal renal tubules. Initial studies showed that apart from reducing blood glucose they also reduce the combined endpoint of ...
Uday Sankar Das, Aritra Paul, Suvro Banerjee   +2 more
doaj   +1 more source

Dapagliflozin use in routine management of heart failure with reduced ejection fraction: outcomes from the Bulgarian cohort of a large observational study (EVOLUTION-HF) [PDF]

Българска кардиология
Introduction: The EVOLUTION-HF is a prospective, multinational, real-world study designed to describe the demographic and clinical characteristics of patients initiating dapaglifl ozin for heart failure with reduced ejection fraction (HFrEF) in
I. Gruev, K. Bletzova, I. Deenichina, G. Goranov, K. Gospodinov, G. Gyuzelev, M. Mihalev, S. Petranov, S. Yovev, V. Velchev   +9 more
doaj   +3 more sources

Clinical characteristics and outcomes of heart failure with preserved, mildly reduced, and reduced ejection fraction: A 6-month follow-up study

Medical Journal of Babylon, 2022
Background and Objective: Heart failure is a major public health problem with 64.3 million people affected all over the world, and it is an important cause for hospital admission and mortality.
Goran Adnan Rahman, Abdulkareem Abdulwahab Al-Othman   +1 more
doaj   +1 more source